Table 1 Interleukin-26 in the airways of children with uncontrolled versus controlled asthma
From: The cytokine interleukin-26 as a biomarker in pediatric asthma
IL-26 (ng/ml) Uncontrolled asthma | n | IL-26 (ng/ml) Controlled asthma | n | p-value* | |
|---|---|---|---|---|---|
All patients | 4.4 (1.9–14) | 48 | 2.4 (1.3–4.5) | 28 | 0.077 |
Low B-EOS (≤ 0.3×109/L) | 4.6 (2.3–13) | 27 | 2.3 (1.3–4.5) | 22 | 0.038* |
High B-EOS (>0.3×109/L) | 4.1 (1.7–16) | 21 | 2.9 (1–31) | 5 | 0.61 |
Low FENO (≤18.3 p.p.b.) | 4.1 (2.2–16) | 23 | 2.0 (1.2–3.6) | 13 | 0.055 |
High FENO (>18.3 p.p.b) | 5.0 (1.8–13) | 25 | 2.7 (1.4–24) | 15 | 0.54 |